Committee for Pharmaceutical Policy

The Committee for Pharmaceutical Policy and Advocacy is a new committee of the K.N.P.S.V., established in 2022. The committee focuses on representing the interests of students whose study association is a department of the K.N.P.S.V. General interest representation includes two related categories: interest representation and policy. Interest representation involves representing the interests of students during and after their studies within the K.N.P.S.V. Examples include improving education, good pharmacy practice, and good working conditions. The “policy” category includes addressing issues. These issues may relate to education, education in other countries, or sustainability (e.g., pharmaceutical waste). Mental health, the pharmaceutical industry in the Netherlands compared to other countries, or antibiotic resistance can also be subjects of such issues.

The Committee for Pharmaceutical Policy and Advocacy collaborates with third parties, including professional associations such as the KNMP, NIA, NVZA, NVKFB, and VJA. They also collaborate with EPSA and IPSF.